Australia markets open in 6 hours 42 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3000+0.0085 (+2.92%)
As of 11:18AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 11.49M
Enterprise value -11.22M
Trailing P/E 0.80
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.97
Price/book (mrq)0.39
Enterprise value/revenue -3.47
Enterprise value/EBITDA -0.92

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 393.49%
S&P500 52-week change 3-7.75%
52-week high 30.6500
52-week low 30.0920
50-day moving average 30.4650
200-day moving average 30.4370

Share statistics

Avg vol (3-month) 3872.6k
Avg vol (10-day) 3859.64k
Shares outstanding 537.76M
Implied shares outstanding 6N/A
Float 821.16M
% held by insiders 126.07%
% held by institutions 120.84%
Shares short (12 Jan 2023) 4429.89k
Short ratio (12 Jan 2023) 40.27
Short % of float (12 Jan 2023) 41.15%
Short % of shares outstanding (12 Jan 2023) 41.14%
Shares short (prior month 14 Dec 2022) 4535.75k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.43
Trailing annual dividend yield 3490.57%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 311 Jan 2023
Ex-dividend date 412 Jan 2023
Last split factor 21:15
Last split date 312 Feb 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 367.44%
Operating margin (ttm)-1,259.34%

Management effectiveness

Return on assets (ttm)-46.47%
Return on equity (ttm)26.37%

Income statement

Revenue (ttm)3.23M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-64.91M
EBITDA -40.39M
Net income avi to common (ttm)11.88M
Diluted EPS (ttm)0.3600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.09M
Total cash per share (mrq)0.73
Total debt (mrq)381k
Total debt/equity (mrq)1.30
Current ratio (mrq)18.40
Book value per share (mrq)0.93

Cash flow statement

Operating cash flow (ttm)-49.3M
Levered free cash flow (ttm)-35.22M